Petah Tikva-based DreaMed Diabetes has just received FDA 510(k) clearance for MODI, a prescription medical application that automatically optimizes insulin dosing for adults with type 2 diabetes. | Read More in JPost.com – Business & Innovation | The Jerusalem Post
- News
- Views
- Topics
- Sources
- Israel in Maps
- Welcome to Zion
- About
Select Page




